Drug Name | Company or Sponsor | Essential Thrombocythemia ET/ Polycythemia Vera PV | Clinical Trial (click ID# for link to trial information) | Phase | Site Locations / More Info |
---|---|---|---|---|---|
Ropeginterferon (BESREMi) | PharmaEssentia | ET | NCT04285086 completed | 3 | Click here for trial info |
Rusfertide | Protagonist Therapeutics, Inc. | PV | NCT05210790 open, recruiting | 3 | click here for more trial info |
Ruxolitinib | Novartis | NCT02386800 open, not recruiting | 4-roll over protocol | click here for more trial info | |
Ropeginterferon (BESREMi) | PharmaEssentia | ET | NCT05482971 open, not recruiting | 2 | click here for more trial info |
Ropeginterferon (BESREMi) | PharmaEssentia | PV | NCT05481151 open, not recruiting | 3 | click here for more trial info |
PTG-300 | Protagonist Therapeutics, Inc. | PV | NCT04057040 active, not recruiting | 2 | Click here for more trial info |
Bomedemstat | Merck | PV/ET | NCT06351631 open, recruiting | 3 | Click here for trial info |
Pacritinib | CTI BioPharma | NCT03165734 open, recruiting | 2 | Click here for more trial info | |
Sapablursen | Ionis Pharmaceuticals, Inc. | PV | NCT05143957 open, recruiting | 2 | Click here for trial info |
Ruxolitinib | Novartis | NCT02577926 open, not recruiting | 2 | click here for trial info | |
Navtemadlin (KRT-232) | Kartos | No | NCT03669965 unknown status | 2 | click here for trial info |
NCT03069326 | Incyte | NCT03069326 open, not recruiting | 2 | Click here for trial info | |
SLN124 | Silence Therapeutics | PV | NCT05499013 open, recruiting | 1/2 | Click here for trial info |
Bomedemstat | Merck | ET | NCT0679879 open, recruiting | 3 | Click here for trial info |
Bomedemstat | Merck | ET | NCT06456346 open, recruiting | 3 | Click here for trial info |
VAC85135 Ipilimumab | Janssen Research & Development, LLC | ET/PV | NCT05444530 active, not recruiting | 1 | Click here for trial info |
Ropeginterferon (BESREMi) | PharmaEssentia | PV | NCT06290765 coming soon, not yet recruiting | 4 | Click here for trial info |